Catch the Latest Buzz: Weekly News Release Highlights

$LIPO Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the dosing of the first two patients with LP-310 in its Phase 2a clinical trial in Oral Lichen Planus (OLP) patients.

$STSN StemSation International (OTC: STSN), a South-Florida-based company that has licensed technology for the production and distribution of flavored, canned oxygen products, is announcing new business initiatives for the upcoming months.

$ABQQ AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its financial results for the period ended May 31, 2024. The financial results have been filed in a 10-Q with the U.S. Securities and Exchange Commission (the "SEC").

$SKYX SKYX Platforms Corp. (NASDAQ: SKYX) Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products.

$OCX Oncocyte Corp.  (Nasdaq: OCX), a molecular diagnostics technology company, announced the recent publication of a case series of two kidney transplant patients who were monitored for antibody-mediated rejection (AMR) using its proprietary VitaGraft™ Kidney diagnostic test. Patients were tested before, during and after treatment with daratumumab, an anti-CD38 monoclonal antibody. The study underscores the significant potential of using repeated VitaGraft Kidney measurements to monitor the efficacy of anti-CD38 therapy.

$BSEM BioStem Technologies (OTC: BSEM) Reports Record Second Quarter 2024 Revenue of $74.5 Million.

• Company reports transformative second-quarter revenue, contributing to a record total of $116.4 million in revenue for the first half of 2024

• AmnioWrap2 continues to be a major growth driver achieving an impressive 56.5% sequential revenue increase compared to Q1 2024

• Achieves second consecutive quarter of positive net income with $6.3 million

• Generated Adjusted Q2 2024 EBITDA of $10.0 million

$MRNJ Metatron Apps Inc (OTC: MRNJ) ($MRNJ), leading developer of over 1000 mobile apps proudly introduces QuantumBeam, a groundbreaking service that harnesses AI-designed and controlled cloud technology to deliver continuous energy transmission through quantum entanglement. This cutting-edge platform offers unparalleled benefits such as enhanced vitality, stress reduction, and EMF mitigation, backed by rigorous scientific studies demonstrating its effectiveness.

$SOTK Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, is pleased to announce the receipt of an additional $2.95 million order from an existing clean energy customer. This new order, identical in value and scope to a recent record-breaking order from the same customer, reinforces Sono-Tek’s position as a key player in the clean energy sector.

$FOMI Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today provided its fiscal year-end stockholder update.

$AMS American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the second quarter ended June 30, 2024.

• Revenue increases 27% year over year

• Reports gain of $3.7 million from strategic acquisition of Rhode Island Radiation Therapy Cancer Centers

• Now treating patients at the new Puebla, Mexico center

• Conference Call on August 14^th at 6:30 pm ET

$AMPG AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced its financial results for the second quarter ended June 30, 2024. The company plans to host an investor call within two weeks after today.

$WENA ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA), a U.S.-based biotechnology company focused on developing cell and gene-based treatments for aging and age-related diseases; today announced the grant and issuance of U.S. Patent No. 12,036,268 (“the 268 patent”) covering the secreted RNA splice variant of the human Klotho gene, referred to as “s-KL”, for the treatment of cognitive and neurodegenerative diseases.

$SOTK Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, announced today that it will be presenting at the upcoming Virtual Investor Summit on August 20, 2024.